Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Role of Lncrna Pvt1 in the Progression of Urological Cancers: Novel Insights Into Signaling Pathways and Clinical Opportunities Publisher Pubmed



Hashemi M1, 2 ; Gholamrezaie H1 ; Ziyaei F1, 2 ; Asadi S1, 2 ; Naeini ZY1, 3 ; Salimian N1, 4 ; Enayat G1 ; Sharifi N1 ; Aliahmadi M1 ; Rezaie YS1 ; Khoushab S1, 2 ; Rahimzadeh P5 ; Miri H6 ; Abedi M7 Show All Authors
Authors
  1. Hashemi M1, 2
  2. Gholamrezaie H1
  3. Ziyaei F1, 2
  4. Asadi S1, 2
  5. Naeini ZY1, 3
  6. Salimian N1, 4
  7. Enayat G1
  8. Sharifi N1
  9. Aliahmadi M1
  10. Rezaie YS1
  11. Khoushab S1, 2
  12. Rahimzadeh P5
  13. Miri H6
  14. Abedi M7
  15. Farahani N1
  16. Taheriazam A1, 8
  17. Nabavi N9
  18. Entezari M1, 2
Show Affiliations
Authors Affiliations
  1. 1. Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  2. 2. Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  3. 3. Department of Cellular and Molecular Biology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  4. 4. Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
  5. 5. Surgical Research Society (SRS), Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Faculty of Medicine, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
  7. 7. Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Department of Orthopedics, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  9. 9. Victoria, V8V 1P7, BC, Canada

Source: Cellular Signalling Published:2025


Abstract

Urologic malignancies, encompassing cancers of the kidney, bladder, and prostate, represent approximately 25 % of all cancer cases. Recent advances have enhanced our understanding of PVT1's crucial functions. Long noncoding RNAs influence both the onset and development of cancer, as well as epigenetic alterations. Recent findings have focused on PVT1's mechanism of action across several malignancies, particularly urologic cancers. Understanding the various functions of PVT1 linked to cancer is necessary for the development of cancer detection and treatment when PVT1 is dysregulated. Furthermore, recent advancements in genomic and epigenetic research have elucidated the complex regulatory networks that control PVT1 expression. Comprehending the intricate role of PVT1 Understanding the complex function of PVT1 in urologic cancers has substantial clinical implications. Here, we summarize some of the most recent findings about the carcinogenic effects of PVT1 signaling pathways and the possible treatment strategies for urological malignancies that target these pathways. © 2025 Elsevier Inc.
Other Related Docs
12. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
14. Modulation of Cancer Cell Signaling by Long Noncoding Rnas, Journal of Cellular Biochemistry (2019)
16. Critical Roles of Long Noncoding Rnas in Breast Cancer, Journal of Cellular Physiology (2020)
20. Microrna and Gynecological Cancers: Focus on Mir-195, Pathology Research and Practice (2023)
23. Continued Increase in Incidence of Kidney Cancer in Iran and Its 31 Provinces, International Journal of Cancer Management (2024)
24. Long Non-Coding Rna Snar Promotes Proliferation in Egfr Wild Type Non-Small Cell Lung Cancer Cells, International Journal of Molecular and Cellular Medicine (2021)
27. Lncrnas Roles in Chemoresistance of Cancer Cells, Current Molecular Medicine (2022)
43. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)